Pathogenic relevance of Lactobacillus:: a retrospective review of over 200 cases

被引:293
作者
Cannon, JP
Lee, TA
Bolanos, JT
Danziger, LH
机构
[1] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60611 USA
[2] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Serv Pharm, Hines, IL 60141 USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gen Internal Med,Ctr Healthcare Studies, Chicago, IL 60611 USA
[4] Univ Illinois, Coll Pharm, Ctr Pharmacoecon Res, Chicago, IL 60612 USA
[5] Univ Illinois, Dept Med, Infect Dis Sect, Chicago, IL 60612 USA
[6] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Midw Ctr Hlth Serv & Policy Res, Hines, IL 60141 USA
关键词
D O I
10.1007/s10096-004-1253-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Given that Lactobacillus has been reported to be the causative pathogen in many types of infection despite debate regarding the organism's clinical significance, a literature review was conducted to investigate the treatments and outcomes of Lactobacillus infections reported to date. In this article, the characteristics of over 200 reported cases of Lactobacillus-associated infections are summarized. Lactobacillus was found to be frequently associated with endocarditis and bacteremia. Lactobacillus was also associated with a variety of other infections including, but not limited to, peritonitis, abscesses, and meningitis. The species casei and rhamnosus were the most common. The isolates tended to be most sensitive to erythromycin and clindamycin and most resistant to vancomycin. The species that was most sensitive to vancomycin was acidophilus. The overall mortality rate was nearly 30%. There was a significant association between mortality and polymicrobial infection (P=0.004). In the subset of patients with bacteremia, increased mortality was associated with inadequate treatment (P=0.001) and polymicrobial bacteremia (P=0.044).
引用
收藏
页码:31 / 40
页数:10
相关论文
共 113 条
[81]  
Rogasi P G, 1998, Ann Ital Med Int, V13, P180
[82]   TOXICITY OF LACTOBACILLUS CASEI [J].
ROSAN, B ;
HAMMOND, BF .
JOURNAL OF DENTAL RESEARCH, 1965, 44 (04) :783-&
[83]   VANCOMYCIN-RESISTANT GRAM-POSITIVE BACTERIA ISOLATED FROM HUMAN SOURCES [J].
RUOFF, KL ;
KURITZKES, DR ;
WOLFSON, JS ;
FERRARO, MJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (10) :2064-2068
[84]  
SACKS PC, 1992, J REPROD MED, V37, P331
[85]   Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on Probiotic L-Rhamnosus GG [J].
Salminen, MK ;
Rautelin, H ;
Tynkkynen, S ;
Poussa, T ;
Saxelin, M ;
Valtonen, V ;
Järvinen, A .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (01) :62-69
[86]   Lactobacillus bacteremia during a rapid increase in Probiotic use of Lactobacillus rhamnosus GG in Finland [J].
Salminen, MK ;
Tynkkynen, S ;
Rautelin, H ;
Saxelin, M ;
Vaara, M ;
Ruutu, P ;
Sarna, S ;
Valtonen, V ;
Järvinen, A .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (10) :1155-1160
[87]   Safety of Lactobacillus strains used as probiotic agents -: Reply [J].
Salminen, S ;
Arvilommi, H .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (09) :1284-1285
[88]   Probiotics demonstrating efficacy in clinical settings [J].
Salminen, S ;
Arvilommi, H .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (11) :1577-1578
[89]   CAPD PERITONITIS CAUSED BY LACTOBACILLUS-RHAMNOSUS [J].
SANYAL, D ;
BHANDARI, S .
JOURNAL OF HOSPITAL INFECTION, 1992, 22 (04) :325-327
[90]   Lactobacilli and bacteremia in southern Finland, 1989-1992 [J].
Saxelin, M ;
Chuang, NB ;
Chassy, B ;
Rautelin, H ;
Makela, PH ;
Salminen, S ;
Gorbach, SL .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (03) :564-566